Clinical Trials Directory

Trials / Terminated

TerminatedNCT01292733

Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer

Ovarian Cancer Early Detection Screening Program

Status
Terminated
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
534 (actual)
Sponsor
Swedish Medical Center · Academic / Other
Sex
Female
Age
30 Years
Healthy volunteers
Accepted

Summary

The main purpose of this program is to see whether periodically measuring CA-125 (tumor marker) levels in the blood and undergoing transvaginal ultrasounds over time will be effective in the early detection of ovarian cancer.

Detailed description

The program will offer twice yearly CA-125 blood tests and annual transvaginal ultrasounds to monitor women at high risk for ovarian cancer. In addition to the main purpose of providing ovarian cancer screening, the researchers would also like to build a repository of blood specimens for use in ovarian and breast cancer research and to offer genetics counseling sessions to help educate women about risk-reducing options.

Conditions

Interventions

TypeNameDescription
OTHERLaboratory Tumor Marker AnalysisPerformed every 6 months, these blood samples will be drawn to measure the concentration of CA125 tumor marker. Remaining samples will be stored in a specimen repository for use in future research for ovarian and breast cancer tumor markers.
OTHERTransvaginal UltrasoundPerformed annually, these pelvic ultrasounds will be used used to look for 1) enlargement of one or both ovaries or 2) suspicious or indeterminate morphometric parameters, determined by the presence of intracystic papillations, and/or mural nodularity.
OTHERHealth Status QuestionnairePerformed every 6 months, these questionnaires will ask about your health and medical history, environmental exposures, and family history.

Timeline

Start date
2009-08-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2011-02-09
Last updated
2016-01-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01292733. Inclusion in this directory is not an endorsement.